1. Home
  2. RIGL vs GCMG Comparison

RIGL vs GCMG Comparison

Compare RIGL & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • GCMG
  • Stock Information
  • Founded
  • RIGL 1996
  • GCMG 1971
  • Country
  • RIGL United States
  • GCMG United States
  • Employees
  • RIGL N/A
  • GCMG N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • GCMG Finance/Investors Services
  • Sector
  • RIGL Health Care
  • GCMG Finance
  • Exchange
  • RIGL Nasdaq
  • GCMG Nasdaq
  • Market Cap
  • RIGL 537.6M
  • GCMG 611.5M
  • IPO Year
  • RIGL 2000
  • GCMG N/A
  • Fundamental
  • Price
  • RIGL $41.64
  • GCMG $11.37
  • Analyst Decision
  • RIGL Buy
  • GCMG Buy
  • Analyst Count
  • RIGL 6
  • GCMG 4
  • Target Price
  • RIGL $39.83
  • GCMG $14.88
  • AVG Volume (30 Days)
  • RIGL 652.5K
  • GCMG 837.5K
  • Earning Date
  • RIGL 11-04-2025
  • GCMG 11-05-2025
  • Dividend Yield
  • RIGL N/A
  • GCMG 4.17%
  • EPS Growth
  • RIGL 2698.26
  • GCMG N/A
  • EPS
  • RIGL 6.20
  • GCMG 0.32
  • Revenue
  • RIGL $282,076,000.00
  • GCMG $543,085,000.00
  • Revenue This Year
  • RIGL $59.93
  • GCMG $4.88
  • Revenue Next Year
  • RIGL N/A
  • GCMG $11.59
  • P/E Ratio
  • RIGL $6.77
  • GCMG $35.90
  • Revenue Growth
  • RIGL 79.13
  • GCMG 17.40
  • 52 Week Low
  • RIGL $14.63
  • GCMG $11.30
  • 52 Week High
  • RIGL $43.72
  • GCMG $14.48
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 69.25
  • GCMG 30.22
  • Support Level
  • RIGL $34.00
  • GCMG $11.55
  • Resistance Level
  • RIGL $39.56
  • GCMG $11.73
  • Average True Range (ATR)
  • RIGL 2.36
  • GCMG 0.11
  • MACD
  • RIGL 1.09
  • GCMG 0.00
  • Stochastic Oscillator
  • RIGL 91.70
  • GCMG 2.47

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About GCMG GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

Share on Social Networks: